BRIEF-Enigma biomedical announces research collaboration agreement with Biogen Inc and Merck

* Collaboration focused on qualification and validation of Tau imaging agent developed by Merck, MK-6240
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.